Atrayee Bhattacharya

Publications

• Addiction of Merkel Cell Carcinoma to MUC1-C Identifies a Potential New Target for Treatment
  Oncogene. Jun, 2022  |   Pubmed ID: 35688945
• Targeting MUC1-C Suppresses Chronic Activation of Cytosolic Nucleotide Receptors and STING in Triple-Negative Breast Cancer
  Cancers. May, 2022  |   Pubmed ID: 35681561
• DEPENDENCE ON THE MUC1-C ONCOPROTEIN IN CLASSIC, VARIANT AND NON-NEUROENDOCRINE SMALL CELL LUNG CANCER
  Molecular Cancer Research : MCR. May, 2022  |   Pubmed ID: 35612556
• MUC1-C Integrates Type II Interferon and Chromatin Remodeling Pathways in Immunosuppression of Prostate Cancer
  Oncoimmunology. 2022  |   Pubmed ID: 35127252
• MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells
  Molecular Cancer Research : MCR. 04, 2022  |   Pubmed ID: 35022313
• MUC1-C Dictates Neuroendocrine Lineage Specification in Pancreatic Ductal Adenocarcinomas
  Carcinogenesis. 02, 2022  |   Pubmed ID: 34657147
• Role of Flavonoids As Epigenetic Modulators in Cancer Prevention and Therapy
  Frontiers in Genetics. 2021  |   Pubmed ID: 34858475
• MUC1-C Activates the PBAF Chromatin Remodeling Complex in Integrating Redox Balance with Progression of Human Prostate Cancer Stem Cells
  Oncogene. 07, 2021  |   Pubmed ID: 34163028
• MUC1-C Integrates Activation of the IFN-γ Pathway with Suppression of the Tumor Immune Microenvironment in Triple-negative Breast Cancer
  Journal for Immunotherapy of Cancer. 01, 2021  |   Pubmed ID: 33495298
• MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells
  Cancer Research. 02, 2021  |   Pubmed ID: 33323379